Anti-NFASC/ NF/ NRCAML monoclonal antibody

Anti-NFASC/ NF/ NRCAML antibody for FACS & in-vivo assay

Target products collectionGo to NFASC/NFASC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0876-Ab-1/ GM-Tg-hg-MP0876-Ab-2Anti-Human NFASC monoclonal antibodyHuman
GM-Tg-rg-MP0876-Ab-1/ GM-Tg-rg-MP0876-Ab-2Anti-Rat NFASC monoclonal antibodyRat
GM-Tg-mg-MP0876-Ab-1/ GM-Tg-mg-MP0876-Ab-2Anti-Mouse NFASC monoclonal antibodyMouse
GM-Tg-cynog-MP0876-Ab-1/ GM-Tg-cynog-MP0876-Ab-2Anti-Cynomolgus/ Rhesus macaque NFASC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0876-Ab-1/ GM-Tg-felg-MP0876-Ab-2Anti-Feline NFASC monoclonal antibodyFeline
GM-Tg-cang-MP0876-Ab-1/ GM-Tg-cang-MP0876-Ab-2Anti-Canine NFASC monoclonal antibodyCanine
GM-Tg-bovg-MP0876-Ab-1/ GM-Tg-bovg-MP0876-Ab-2Anti-Bovine NFASC monoclonal antibodyBovine
GM-Tg-equg-MP0876-Ab-1/ GM-Tg-equg-MP0876-Ab-2Anti-Equine NFASC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0876-Ab-1/ GM-Tg-hg-MP0876-Ab-2; GM-Tg-rg-MP0876-Ab-1/ GM-Tg-rg-MP0876-Ab-2;
GM-Tg-mg-MP0876-Ab-1/ GM-Tg-mg-MP0876-Ab-2; GM-Tg-cynog-MP0876-Ab-1/ GM-Tg-cynog-MP0876-Ab-2;
GM-Tg-felg-MP0876-Ab-1/ GM-Tg-felg-MP0876-Ab-2; GM-Tg-cang-MP0876-Ab-1/ GM-Tg-cang-MP0876-Ab-2;
GM-Tg-bovg-MP0876-Ab-1/ GM-Tg-bovg-MP0876-Ab-2; GM-Tg-equg-MP0876-Ab-1/ GM-Tg-equg-MP0876-Ab-2
Products NameAnti-NFASC monoclonal antibody
Formatmab
Target NameNFASC
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NFASC benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NFASC/ NF/ NRCAML VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0876
    Target NameNFASC
    Gene ID23114,269116,116690,699444,488565,101083317,512796,100054575
    Gene Symbol and SynonymsD430023G06Rik,mKIAA0756,NEDCPMD,NF,NFASC,NRCAML
    Uniprot AccessionO94856,P97685
    Uniprot Entry NameNFASC_HUMAN,NFASC_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000163531
    Target ClassificationN/A

    The target: NFASC, gene name: NFASC, also named as NF, NRCAML. This gene encodes an L1 family immunoglobulin cell adhesion molecule with multiple IGcam and fibronectin domains. The protein functions in neurite outgrowth, neurite fasciculation, and organization of the axon initial segment (AIS) and nodes of Ranvier on axons during early development. Both the AIS and nodes of Ranvier contain high densities of voltage-gated Na+ (Nav) channels which are clustered by interactions with cytoskeletal and scaffolding proteins including this protein, gliomedin, ankyrin 3 (ankyrin-G), and betaIV spectrin. This protein links the AIS extracellular matrix to the intracellular cytoskeleton. This gene undergoes extensive alternative splicing, and the full-length nature of some variants has not been determined.[provided by RefSeq, May 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.